BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16352706)

  • 1. Fatty acid amide hydrolase (-/-) mice exhibit an increased sensitivity to the disruptive effects of anandamide or oleamide in a working memory water maze task.
    Varvel SA; Cravatt BF; Engram AE; Lichtman AH
    J Pharmacol Exp Ther; 2006 Apr; 317(1):251-7. PubMed ID: 16352706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task.
    Varvel SA; Wise LE; Niyuhire F; Cravatt BF; Lichtman AH
    Neuropsychopharmacology; 2007 May; 32(5):1032-41. PubMed ID: 17047668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
    Lichtman AH; Hawkins EG; Griffin G; Cravatt BF
    J Pharmacol Exp Ther; 2002 Jul; 302(1):73-9. PubMed ID: 12065702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice.
    Wise LE; Long KA; Abdullah RA; Long JZ; Cravatt BF; Lichtman AH
    ACS Chem Neurosci; 2012 May; 3(5):369-78. PubMed ID: 22860205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid amide hydrolase (FAAH) knockout mice exhibit enhanced acquisition of an aversive, but not of an appetitive, Barnes maze task.
    Wise LE; Harloe JP; Lichtman AH
    Neurobiol Learn Mem; 2009 Nov; 92(4):597-601. PubMed ID: 19524055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the sleep-wake patterns in mice lacking fatty acid amide hydrolase.
    Huitron-Resendiz S; Sanchez-Alavez M; Wills DN; Cravatt BF; Henriksen SJ
    Sleep; 2004 Aug; 27(5):857-65. PubMed ID: 15453543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of CB1 receptor knockout mice in the Morris water maze.
    Varvel SA; Lichtman AH
    J Pharmacol Exp Ther; 2002 Jun; 301(3):915-24. PubMed ID: 12023519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Just add water: cannabinoid discrimination in a water T-maze with FAAH(-/-) and FAAH(+/+) mice.
    Wiley JL; Lefever TW; Pulley NS; Marusich JA; Cravatt BF; Lichtman AH
    Behav Pharmacol; 2016 Aug; 27(5):479-84. PubMed ID: 27385208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
    J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.
    Cravatt BF; Demarest K; Patricelli MP; Bracey MH; Giang DK; Martin BR; Lichtman AH
    Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9371-6. PubMed ID: 11470906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates.
    Kangas BD; Leonard MZ; Shukla VG; Alapafuja SO; Nikas SP; Makriyannis A; Bergman J
    J Pharmacol Exp Ther; 2016 Apr; 357(1):125-33. PubMed ID: 26826191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of fatty acid amides in the carrageenan-induced paw edema model.
    Wise LE; Cannavacciulo R; Cravatt BF; Martin BF; Lichtman AH
    Neuropharmacology; 2008 Jan; 54(1):181-8. PubMed ID: 17675189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
    Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
    J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors.
    Wise LE; Shelton CC; Cravatt BF; Martin BR; Lichtman AH
    Eur J Pharmacol; 2007 Feb; 557(1):44-8. PubMed ID: 17217945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.
    Schlosburg JE; Kinsey SG; Lichtman AH
    AAPS J; 2009 Mar; 11(1):39-44. PubMed ID: 19184452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase.
    Naidu PS; Kinsey SG; Guo TL; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2010 Jul; 334(1):182-90. PubMed ID: 20375198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain.
    Glaser ST; Gatley SJ; Gifford AN
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1088-97. PubMed ID: 16278311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.
    Fegley D; Kathuria S; Mercier R; Li C; Goutopoulos A; Makriyannis A; Piomelli D
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8756-61. PubMed ID: 15138300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆(9)-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice.
    Walentiny DM; Gamage TF; Warner JA; Nguyen TK; Grainger DB; Wiley JL; Vann RE
    Eur J Pharmacol; 2011 Apr; 656(1-3):63-7. PubMed ID: 21300050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.